House Judiciary Committee Advances Four Drug Pricing Bills, Although Changes Are Still Likely

 
• By Michael Cipriano
Capitol Building, Washington DC
The House Judiciary Committee advanced four drug pricing bills to the full chamber.

More from Pricing Debate

More from Market Access